- Home
- KURA vs SMBC Comparison
KURA vs SMBC Comparison
Compare KURA & SMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- SMBC
- Stock Information
- Founded
- KURA 2014
- SMBC 1887
- Country
- KURA United States
- SMBC United States
- Employees
- KURA N/A
- SMBC N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- SMBC Banks
- Sector
- KURA Health Care
- SMBC Finance
- Exchange
- KURA Nasdaq
- SMBC Nasdaq
- Market Cap
- KURA 713.5M
- SMBC 613.1M
- IPO Year
- KURA N/A
- SMBC N/A
- Fundamental
- Price
- KURA $10.26
- SMBC $52.87
- Analyst Decision
- KURA Strong Buy
- SMBC Hold
- Analyst Count
- KURA 13
- SMBC 4
- Target Price
- KURA $25.00
- SMBC $63.63
- AVG Volume (30 Days)
- KURA 2.0M
- SMBC 70.8K
- Earning Date
- KURA 11-04-2025
- SMBC 10-22-2025
- Dividend Yield
- KURA N/A
- SMBC 1.72%
- EPS Growth
- KURA N/A
- SMBC 25.22
- EPS
- KURA N/A
- SMBC 5.46
- Revenue
- KURA $83,279,000.00
- SMBC $178,893,000.00
- Revenue This Year
- KURA $68.63
- SMBC $17.00
- Revenue Next Year
- KURA $141.59
- SMBC $7.19
- P/E Ratio
- KURA N/A
- SMBC $9.68
- Revenue Growth
- KURA N/A
- SMBC 10.39
- 52 Week Low
- KURA $5.41
- SMBC $45.10
- 52 Week High
- KURA $19.73
- SMBC $68.69
- Technical
- Relative Strength Index (RSI)
- KURA 57.62
- SMBC 52.65
- Support Level
- KURA $9.08
- SMBC $47.60
- Resistance Level
- KURA $11.06
- SMBC $54.24
- Average True Range (ATR)
- KURA 0.61
- SMBC 1.51
- MACD
- KURA -0.01
- SMBC 0.51
- Stochastic Oscillator
- KURA 59.85
- SMBC 79.37
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.